Suppr超能文献

青光眼引流装置植入、结果和并发症。

Glaucoma Drainage Device Implantation, Outcomes, and Complications.

出版信息

Int Ophthalmol Clin. 2023 Oct 1;63(4):93-101. doi: 10.1097/IIO.0000000000000499. Epub 2023 Sep 27.

Abstract

Glaucoma drainage device (GDD) surgery has gained popularity as a treatment strategy for patients with medically uncontrolled glaucoma. Glaucoma is the leading cause of irreversible blindness in the world and continues to be a major public health issue. While our understanding of glaucoma continues to evolve, the primary treatment for glaucoma continues to be intraocular pressure (IOP) control. When medical treatment fails, glaucoma surgery is considered. GDD implantation is one of the most commonly performed incisional glaucoma surgeries. GDD was originally designed for patients with secondary glaucoma and/or patients who are at an increased risk of failure after trabeculectomy. More recently, its application has been extended to primary glaucoma as the first choice of incisional surgery. This manuscript summarizes recent GDD types, implantation, clinical outcome and complications.

摘要

青光眼引流装置 (GDD) 手术已成为治疗药物无法控制的青光眼患者的一种受欢迎的治疗策略。青光眼是全球导致不可逆性失明的主要原因,仍是一个重大的公共卫生问题。尽管我们对青光眼的认识不断发展,但青光眼的主要治疗方法仍然是眼压 (IOP) 控制。当药物治疗失败时,就会考虑进行青光眼手术。GDD 植入是最常进行的切开性青光眼手术之一。GDD 最初是为继发性青光眼和/或小梁切除术失败风险增加的患者设计的。最近,它的应用已扩展到原发性青光眼,成为切开性手术的首选。本文总结了最近的 GDD 类型、植入、临床结果和并发症。

相似文献

1
Glaucoma Drainage Device Implantation, Outcomes, and Complications.
Int Ophthalmol Clin. 2023 Oct 1;63(4):93-101. doi: 10.1097/IIO.0000000000000499. Epub 2023 Sep 27.
2
Preventing and treating complications of Baerveldt Glaucoma Drainage Device surgery.
Int Ophthalmol Clin. 2004 Spring;44(2):107-36. doi: 10.1097/00004397-200404420-00008.
3
Postoperative outcomes before and after raising the ahmed glaucoma valve occlusion pressure.
Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):353-355. doi: 10.1007/s00417-023-06173-3. Epub 2023 Jul 17.
4
Comment on: Hypotonous malignant glaucoma following glaucoma drainage device implantation.
Indian J Ophthalmol. 2022 Jan;70(1):341-342. doi: 10.4103/ijo.IJO_1962_21.
5
Complications of glaucoma drainage device surgery: a review.
Semin Ophthalmol. 2014 Sep-Nov;29(5-6):397-402. doi: 10.3109/08820538.2014.959199.
6
Management of glaucoma with Boston type 1 keratoprosthesis.
Arq Bras Oftalmol. 2023 Mar-Apr;86(2):137-144. doi: 10.5935/0004-2749.20230026.
7
Xen Luminal Obstruction.
Ophthalmol Glaucoma. 2020 Sep-Oct;3(5):376. doi: 10.1016/j.ogla.2020.04.010.
8
Focal digital pressure for the management of posterior chamber tube shunts: a novel technique.
Br J Ophthalmol. 2014 May;98(5):708. doi: 10.1136/bjophthalmol-2013-304518. Epub 2014 Jan 23.
9
Glaucoma drainage device exposure in Asian eyes.
Clin Exp Ophthalmol. 2015 Jan-Feb;43(1):85-8. doi: 10.1111/ceo.12364. Epub 2014 Aug 7.
10
Ab interno tube ligation for refractory hypotony following non-valved glaucoma drainage device implantation.
Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2271-2278. doi: 10.1007/s00417-019-04400-4. Epub 2019 Jul 22.

引用本文的文献

本文引用的文献

1
Effect of guided Ahmed glaucoma valve implantation on corneal endothelial cells: A 2-year comparative study.
PLoS One. 2023 Feb 14;18(2):e0278340. doi: 10.1371/journal.pone.0278340. eCollection 2023.
2
New glaucoma drainage implants available to glaucoma surgeons.
Curr Opin Ophthalmol. 2023 Mar 1;34(2):176-180. doi: 10.1097/ICU.0000000000000936. Epub 2023 Jan 13.
3
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up.
Ophthalmology. 2022 Dec;129(12):1357-1367. doi: 10.1016/j.ophtha.2022.07.004. Epub 2022 Jul 12.
4
Clinical Outcomes of Ahmed ClearPath Implantation in Glaucomatous Eyes: A Novel Valveless Glaucoma Drainage Device.
J Glaucoma. 2022 May 1;31(5):335-339. doi: 10.1097/IJG.0000000000002013. Epub 2022 Mar 7.
5
One-Year Randomized Comparison of Safety and Efficacy of Trabeculectomy with Mitomycin C Sub-Tenon Injection versus Mitomycin C-Infused Sponges.
Ophthalmol Glaucoma. 2022 Jan-Feb;5(1):77-84. doi: 10.1016/j.ogla.2021.05.006. Epub 2021 May 28.
6
Subconjunctival Injections of Mitomycin C Are Associated with a Lower Incidence of Hypertensive Phase in Eyes with Ahmed Glaucoma Valve.
Ophthalmol Glaucoma. 2021 May-Jun;4(3):322-329. doi: 10.1016/j.ogla.2020.10.004. Epub 2020 Oct 13.
7
Short-term Postoperative Visual Acuity Decrease and Recovery after Ahmed Tube Shunt Procedure for Glaucoma.
Ophthalmol Glaucoma. 2020 Sep-Oct;3(5):384-392. doi: 10.1016/j.ogla.2020.04.006. Epub 2020 Apr 22.
8
Treatment Outcomes Using the PAUL Glaucoma Implant to Control Intraocular Pressure in Eyes with Refractory Glaucoma.
Ophthalmol Glaucoma. 2020 Sep-Oct;3(5):350-359. doi: 10.1016/j.ogla.2020.05.001. Epub 2020 May 11.
9
Corneal Endothelial Cell Loss after Baerveldt Glaucoma Implant Surgery.
Ophthalmol Glaucoma. 2021 Jan-Feb;4(1):20-31. doi: 10.1016/j.ogla.2020.06.012. Epub 2020 Jul 4.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验